September 22, 2016, Davis, CA. – Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII), a leading global provider of bio-based pest management and plant health products, announced today that its Majestene® Bionematicide product has won the Biopesticide category in the 2016 Agrow Awards held in London yesterday.

The prestigious Agrow Awards (, presented by Agrow, a leading information provider for the global crop protection industry, features 14 categories in areas such as R&D, formulation, innovation, collaboration, marketing, business strategy and corporate responsibility. Winners are judged by an independent panel of industry experts. To be eligible for the awards, products were required to be formulated in a way that is acceptable to users and distributors, while also providing the ability to forge a path in a market dominated by synthetic chemicals.

“We are pleased and honored to have Majestene awarded Best New Biopesticide,” said Pam Marrone, CEO of MBI. “With MBI products Regalia and Grandevo being previous Agrow Award winners in the Best New Biopesticide category, this recognition of a third MBI product is a true testament to our success in bringing new agricultural innovations to market that help growers protect and improve their crop production. On behalf of everyone at MBI, I would like to thank the Agrow Awards team for their recognition and for their continued support in advancing awareness about biopesticides and their important role in agriculture.”

Tony Torres, Product Marketing Manager, Insecticides & Nematicides, added, “Receiving this award allows us to further demonstrate that Majestene provides value in the fight against nematodes, which are reported to cause $80 billion annually in global damage to crops. Farmers now have a unique tool to suppress nematodes and protect yield in a wide variety of crops, including: potatoes, strawberries, tomatoes, cotton, corn, soybeans and outside the US, bananas.”

Majestene, which was launched earlier in 2016, is labeled for a wide array of crops against multiple nematodes such as root knot, cyst, sting, burrowing and lance and is approved for use in conventional and organic systems. It is available in a liquid formulation and can be applied by ground, with no limit on the number of applications allowed per season. Majestene has the minimum four-hour re-entry interval for farmworkers. The product is non-toxic to fish, birds and most beneficial insects, and also has the advantages of a zero-day pre-harvest interval (PHI) and an exemption from MRL (maximum residue level) tolerances — a measure of pesticide residue limits that must be met for most food crop exports.

About Marrone Bio Innovations
Smart. Natural. Solutions.

Marrone Bio Innovations, Inc. (NASDAQ: MBII) strives to lead the movement to a more sustainable world through the discovery, development and promotion of biological products for pest management and plant health. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have four products for agriculture on the market (Regalia®, Grandevo®, Venerate® and Majestene®), and also distribute Bio-tam 2.0® for Isagro USA in the western U.S. MBI also markets Zequanox® for invasive mussels for water markets. We also have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe.

Marrone Bio Innovations Forward Looking Statements
This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations and plans, including assumptions underlying such statements, are forward-looking statements, and should not be relied upon as representing MBI’s views as of any subsequent date. Examples of such statements include statements regarding the potential of and market for MBI’s Majestene product and its use and value to growers. Such forward-looking statements are based on information available to the Company as of the date of this release and involve a number of risks and uncertainties, some beyond the Company’s control, that could cause actual results to differ materially from those anticipated by these forward-looking statements, including risks associated with marketing Majestene with MBI’s principal customers, competition in the market for pest management products, lack of understanding of bio-based pest management products by customers and growers, adverse decisions by regulatory agencies and other relevant third parties and the impact of weather conditions and other factors affecting use of crop protection products . Additional information that could lead to material changes in MBI’s performance is contained in its filings with the SEC. MBI is under no obligation to, and expressly disclaims any responsibility to, update or alter forward-looking statements contained in this release, whether as a result of new information, future events or otherwise.

Marrone Bio Innovations Contacts:
Nancy M. Hood, VP Marketing
(530) 302-8290

Marrone Bio Innovations Investor Contact:
James Palczynski, ICR